DCF — ST. MARY MEDICAL CENTER
Enterprise Value: $-760.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-760.9M
Enterprise Value
$-238.1M
PV of Cash Flows
$-522.8M
PV of Terminal Value
$-841.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $399.1M | $-48.8M | -12.0% | $-65.7M | $-59.7M |
| Year 2 | $411.1M | $-46.2M | -11.0% | $-63.6M | $-52.5M |
| Year 3 | $423.4M | $-43.3M | -10.0% | $-61.2M | $-46.0M |
| Year 4 | $436.1M | $-42.4M | -10.0% | $-60.9M | $-41.6M |
| Year 5 | $449.2M | $-42.6M | -9.0% | $-61.6M | $-38.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-760.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$387.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12730443524181165
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5